baber/WOPTO huggingface dataset:
Patent JP-2001518997-A (JP)
Title: 作業装置、特に地面圧縮のためのスタンピング装置又はハンマー
IPC: E02D3/074
Filed: 1998-04-01
Abstract: (57)【要約】
作業装置、特に地面圧縮のためのスタンピング装置（１０）又はハンマーは、相対的に互いに直線的に往復運動するように駆動可能な２つの質量体、つまり、駆動モータ（２０）を有する上部質量体と、スタンピング式又は打撃式の作業質量体とを有している。この作業質量体は、前記モータ（２０）によってクランク機構（２６，２８，３０）及びばねセットを介して上部質量体に対して相対的に運動することができる。上部質量体の運動をできるだけ小さく抑えるためには、作業質量体の運動距離の少なくとも大部分にわたって、前記作業質量体の運動に対して逆方向でモータによって駆動可能な対応質量体（４０）が付加的に設けられており、この場合、有利にはクランク機構に結合されたばねセットの端部（３４）の運動と、対応質量体（４０）の運動とが、クランク角に関して、ばねセットの構造パラメータに基づき導出された位相ずれを１８０°から差し引いた分だけ、相互にずらされている。
Patent JP-2001520554-A (JP)
Title: ブラインド洗浄機
IPC: A47L4/00
Filed: 1998-04-09
Abstract: (57)【要約】
既存の形式の洗浄機は複数の部材から構成されており、移動可能な洗浄容器と、搬送可能なシャワーヘッドと、捕集パンとから成っている。これらは全て機能的に相互に接続されている。これにより、この洗浄機の操作及び搬送は困難である。従って、捕集パン（２）の外法寸法を洗浄容器（１）の内法寸法に合わせて、捕集パン（２）を洗浄容器（１）に挿入可能に構成することが提案される。
Patent MX-152061-A (MX)
Inventor: STIROS PAUL
IPC: A61K8/00
Filed: 1981-08-31
Abstract: Clear, aqueous liquid skin cleansing compositions comprising saturated and unsaturated potassium soaps and free fatty acid.
Patent MX-155652-A (MX)
Inventor: AHLSTROM JOHN K
IPC: G06F12/08
Filed: 1982-05-24
Abstract: A digital data processing system has a memory organized into objects containing at least operands and instructions. Each object is identified by a unique and permanent identifier code which identifies the data processing system and the object. The system further uses multilevel microcode techniques for controlling sequences of microinstructions and for controlling the interval operations of the processor. The system uses a protection technique to prevent unauthorized access to objects by users who are identified by a subject number which identifies the user, a process of the system for executing a user's procedure, and the type of operation of the system to be performed by the user's procedure. An access control list for each object includes an access control list entry for each subject having access rights to the object and means for confirming that a particular active subject has access rights to a particular object before permitting access to the object. The system also includes stacks for containing information relating to the current state of execution of the system.
Patent NZ-205166-A (NZ)
Title: Soft multifocal contact lens:upper periphery defined by truncated semi-circle
Inventor: BAYSHORE C A
IPC: G02C7/04
Filed: 1983-08-05
Abstract: A soft, multifocal contact lens of the segmented type intended to translate vertically between the near-vision and distance-vision modes, characterized in that the superior portion of the lens is equiangularly truncated from points on either side of the vertical axis at the apex of the lens to points on each respective side proximal the horizontal axis of the lens.
Patent NZ-206336-A (NZ)
Title: Catalytic production of hydrocarbons from synthesis gas and steam
Inventor: MINDERHOUD J K
IPC: B01J23/74
Filed: 1983-11-21
Abstract: Process for the preparation of hydrocarbons by contacting a feed comprising hydrogen, carbon monoxide and steam, the quantity of steam being 10-40%v, calculated on the H2/CO/H2O mixture, at elevated temperature and pressure with a silica supported catalyst comprising 10-40 pbw cobalt and 0.1-150 pbw zirconium, titanium or chromium per 100 pbw silica which catalyst has been prepared by impregnation and/or kneading.
Patent NZ-207698-A (NZ)
Title: Apparatus for sealing groups of business forms into form sets
Inventor: SCHULTZ E G
IPC: B65H37/04
Filed: 1984-03-30
Abstract: The aligner sealer (10) includes a base or frame (14), heating structure (16), infeed conveyor structure (18), output conveyor structure (20) and stacking rack (22). Form sheets are fed in groups on the infeed conveyor (18) through the heating stucture (16), where they are sealed into form sets, then fed onto the outfeed conveyor (20) and stached against the rack (22). The infeed conveyor structure (18) includes means for aligning the from sheets of the groups before the groups enter the heating means (16).
Patent NZ-217062-A (NZ)
Title: Load breaking switch-three pole operation
Inventor: MATLANGA M
IPC: H01H33/02
Filed: 1986-08-01
Abstract: The invention relates to an on-load isolating switch of a high-tension switching unit (three-phase current switch) consisting of three switching elements (11, 12, 13) which in each case connect two electrical contacts and are provided with a latching device, which switching elements can be moved from the switched-on position into the switched-off position and vice versa by means of an insertion and extraction tool (manual snap-action mechanism). In order to be able to switch off or on all three switching elements (11, 12, 13) and thus all three phases (RYB) of the supply network simultaneously, the three switching elements (11, 12, 13) are connected to one another by means of a dielectric bridge (10), such that, on operation of one of the switching elements (11 to 15), all three switching elements (11 to 13) can be switched in unison. In a preferred method, only the centre switching element (12) is provided with a latching device (24) and can be operated by means of the tool (50). <IMAGE>
Patent NZ-221091-A (NZ)
Title: Preparation of a porous ceramic composite with an integrally formed dense surface
Inventor: DWIVEDI RATNESH KUMAR
IPC: C04B35/58
Filed: 1987-07-16
Abstract: There is disclosed a method for making a self-supporting ceramic composite article having a porous core bearing a dense surface layer formed integrally with said core. A preform comprises a filler material and parent metal distributed therethrough, wherein the volume percent of parent metal is sufficient to form a volume of oxidation reaction product exceeding the total volume available within said preform. The parent metal is molted and reacted with an oxidant to form an oxidation reaction product filling the spatial volume and leaving voids. The reaction is continued to further transport molten parent metal through the oxidation reaction product to at least one surface of the preform to form oxidation reaction product on said surface substantially free of voids thereby forming a relatively dense surface layer.
Patent NZ-224984-A (NZ)
Title: Preparation of 4-(3,4-dichlorophenyl)-4-phenylbutanoic acid: intermediates therefor
Inventor: QUALLICH GEORGE JOSEPH
IPC: C07C49/697
Filed: 1988-06-10
Abstract: A novel three-step process for preparing 4-(3,4-dichlorophenyl)-4-phenylbutanoic acid is disclosed, which involves (1) reducing 4-(3,4-dichlorophenyl)-4-ketobutanoic acid to 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid; (2) then converting the intermediate hydroxy acid formed in the first step to 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone, and (3) thereafter reacting the resulting gamma-butyrolactone compound with benzene in a Friedel-Crafts type reaction to form the desired final product. The latter compound is known to be useful as an intermediate leading to 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone and ultimately, to cis-(1S)(4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrah ydro-1-naphthaleneamine (sertraline), which is known to be a preferred anti-depressant agent in the field of medicinal chemistry. The aforementioned 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone and 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid are both novel compounds. There is also disclosed a novel process for converting 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone directly to 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone, as well as an alternate novel process for converting 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid directly to this same key intermediate.
Patent NZ-236755-A (NZ)
Title: Composition for alleviating menopausal symptoms comprising melatonin and an estrogen and/or an androgen.
Inventor: COHEN MICHAEL
IPC: A61K31/565
Filed: 1991-01-14
Abstract: A method of alleviating climacterial menopausal and post-menopausal symptoms in females comprises administering an effective amount of a composition comprising melatonin and at least one estrogen and/or at least one androgen.
Patent NZ-237483-A (NZ)
Title: Preparation of uniformly sized particles in the range of 1 to 50#m#m
Inventor: FRAZZA MARK STEPHEN
IPC: C08F/
Filed: 1991-03-19
Abstract: A process for making uniformly sized polymer particles, having a final particle size of 1-50 micron, comprises (a) combining sufficient free-radical-polymerisable, water-insoluble monomer, or mixt thereof, with an aq dispersion of seed polymer particles, at a rate such that the amt of monomer(s) equal to the total initial wt of the seed polymer particles is combined with the dispersion over 45-120 (pref 60-90) mins, in the presence of a dispersion stabiliser and an oil-soluble, free-radical polymsn initiator. The temp is at least high enough to activate the initiator, and (b) maintaining the temp until polymsn is complete. Opt these steps are repeated until the required final particle size is achieved
Patent NZ-273982-A (NZ)
Title: Detection of inhibitors of aminoacyl-trna synthetases, identification of potential herbicides and antibiotics
Inventor: HAWKES TIMOTHY ROBERT
IPC: C07D309/10
Filed: 1994-10-04
Abstract: An assay for detecting inhibitors of amino acyl-tRNA synthetases by incubating a divalent metal cation, ATP, tRNA, a non-cognate amino acid, inorganic pyrophosphatase and aminoacyl-tRNA synthetase, which aminoacyl-tRNA synthetase is in at least a partially pure form, both with and without a potential inhibitor, converting the resulting pyrophosphate to phosphate, detecting phosphate production, and comparing the phosphate production results obtained.
Patent NZ-278967-A (NZ)
Title: Data exchange system; comprises portable data processing units, ic card memory stores data structures for different applications
Inventor: JONG EDUARD KAREL DE
IPC: G06F21/12
Filed: 1995-02-08
Abstract: Data exchange system comprising at least one portable data processing unit (5) comprising data communication means (14), processing means (15) and memory means (16), the latter comprising an executive program (17) and one or more application descriptions (18(1) ... 18(n)), each application description comprising at least one interaction context (19(1) ... ) comprising commands, data elements, data references, procedures, access conditions, and external references; the structure of the data elements and the data references as well as other references is chosen in such a way that a very efficient use of the restricted memory space of e.g. smart cards is obtained. <IMAGE>
Patent NZ-323559-A (NZ)
Title: Pull-down member on temple of eyeglass frame
Inventor: HIRSCHMAN JASON
IPC: G02C5/14
Filed: 1996-11-15
Abstract: A pull-down member is pivotably and ratchetly attached to the distal end of the end-piece of each eyeglass temple. Each pull-down member is pivotably displaceable to the end-piece at a series of angles, and thereby provides a snug fit of the eyeglasses on the user's face. In one embodiment, the pull-down member comprises a disk-shaped core having an edge on which is attached an elongated appendage which is the portion of the pull-down member abutting against the user's ear. The edge of the core also includes a series of notches which are biased by a ball and spring mechanism to provide the pivotable and ratchetable displacement of the pull-down member relative to the end-piece of the eyeglass temple. In another embodiment of the pull-down member, the core has a central opening defined by a series of teeth. A split-pin having a complementary series of teeth along an outer surface thereof engages the toothed opening of the core to provide the pivotable and ratchetable displacement of the pull-down member relative to the end-piece of the eyeglass temple.
Patent NZ-333983-A (NZ)
Title: Method of treating sinusitis with uridine triphosphates and related compounds
Inventor: JACOBUS KARLA
IPC: C07H19/167
Filed: 1997-07-03
Abstract: This method of treating sinusitis is by using nucleoside phosphates selected from UTP (uridine 5-triphosphate), ATP (adenosine triposphate, CTP (cytosine triphosphate) or derivatives thereof, or using dinucleoside tetraphosphates of adenosine or uridine.
Patent NZ-334236-A (NZ)
Title: Composition comprising GnRH, lecithin and stearin
Inventor: TRIGG TIMOTHY ELLIOT
IPC: A61K9/70
Filed: 1997-09-01
Abstract: A pharmaceutical and/or veterinary formulation for sustained release of a peptide agonist or analogue, comprising about 2-15 % (w/w) of at least one peptide agonist or analogue other than deslorelin (on an active basis), about 0.5-3.5 % (w/w) lecithin and the balance sterin. The formulation preferably comprises a GnRH agonist or analogue and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial, particularly prostate cancer, ovarian and breast cancer, and benign prostatic hyperplasia in dogs.
Patent NZ-334294-A (NZ)
Title: Metabolically engineered lactic acid bacteria and means for providing same
Inventor: ARNAU JOSE
IPC: C12N9/02
Filed: 1997-08-20
Abstract: The complete DNA sequences for adhE and pf1 genes of Lactococcus lactis, recombinant replicons comprising one or both of these genes or comprising mutants or variants hereof including mutants in which the genes are inactivated, and recombinant lactic acid bacteria comprising such a replicon are provided. The gene sequences and/or sequences regulating the expression of the genes can be modified to provide metabolically engineered lactic acid bacteria which have an enhanced or reduced production of one or more metabolites resulting from citrate and/or sugar fermentation. Such metabolically modified cells are useful as starter cultures in the manufacturing of food products and animal feed having improved flavour and/or shelf life, including dairy products, or they can be used directly in the manufacturing of a lactic acid bacterial metabolite.
Patent NZ-336143-A (NZ)
Title: Benzothiophenecarboxamide derivatives and pgd 2 antagonists comprising them
Inventor: HONMA TSUNETOSHI
IPC: A61P37/08
Filed: 1997-12-10
Abstract: A compound of the formula (I) is disclosed, wherein R represents hydrogen, alkyl, alkoxy, halogen, hydroxy, acyloxy or optionally substituted arylsulfonyloxy, X represents hydrogen or alkyl, and the double bond on the alpha-chain has E configuration or Z configuration, provided that the compound of the formula (II) wherein R1a represents hydrogen, alkyl or alkoxy, X is as defined above, and the double bond on the alpha-chain has E configuration or Z configuration is excluded, a pharmaceutically acceptable salt thereof, or a hydrate thereof.  Such compounds have PGD2-antagonistic activities, inhibitory activities against infiltration of eosinophils, and is useful as a drug for treating diseases, such as systemic mastocytosis and disorder of systemic mast cell activation, as well as tracheal contraction, asthma, allergic rhinitis, allergic conjunctivitis, urticaria, ischemic reperfusion injury, inflammation and atopic dermatitis.
Patent NZ-503306-A (NZ)
Title: Carton with panel locking tabs
Inventor: IKEDA TAMIO
IPC: B65D71/12
Filed: 1998-08-20
Abstract: A carton locking device includes first (12) and second (20) overlapping panels and a lock for securing the panels (12, 20) to each other. The lock includes a locking tab (62) struck from the first panel (12) and a retaining tab (72) struck from the second panel (20) and defining a locking aperture (102) in the second panel (20). The locking tab (62) is foldably connected at is proximal end edge to the first panel (20) and extends to its first free end edge opposite to the proximal end edge. The retaining tab (72) is foldably joined at its proximal end to the second panel (20) and extends to its free end edge opposite to the proximal end edge. The lock is formed by engaging the two tabs (62,72), which are folded in an angular relationship so that the locking tab (62) is pushed through the locking aperture (102) and engages the retaining tab (72). The tabs (62,72) remain in engagement by the cooperation of a projecting tongue (84) on the locking tab (62) being received in a notch in the free end of the retaining panel (72).
Patent NZ-505921-A (NZ)
Title: 1-[5-(2,6-Dimethylpiperidino)pentyl] substituted quinolone serine protease inhibitors and their use for treating thrombin related disorders
Inventor: DUDLEY DANETTE ANDREA
IPC: C07D417/14
Filed: 1998-12-15
Abstract: Quinolinones of Formula (I) which display inhibitory effects on serine proteases such as factor Xa, thrombin and/or factor VIIa, wherein: A is selected from CH2, CH, C(alkyl); B is selected from H, alkyl, cycloalkyl, heteroalkyl, cycloalkylalkyl, heteroalkylalkyl, aryl, arylalkyl, heterocycle, heterocycloalkyl, each optionally substituted with R1 and R2; D is selected from H, alkyl, cycloalkyl, heteroalkyl, cycloalkylalkyl, heteroalkylalkyl, aryl, arylalkyl, heterocycle, heterocycloalkyl, each optionally substituted with R1 and R2; E is absent or selected from O, S, NH; F is selected from N, NCH2, CH2N; G is absent or selected from alkyl, alkyl interrupted by one or more heteroatoms, cycloalkyl, cycloalkyl interrupted by one or more heteroatoms; J is selected from aryl or heterocycle each optionally substituted with R1 and R2, provided that when G is -CH2- and K is absent, J is not an unsubstituted aryl or an aryl substituted with R1=H and R2=H; K is absent or selected from an alkyl, alkyl interrupted by one or more heteroatoms, cycloalkyl interrupted by one or more heteroatoms, cycloalkylalkyl interrupted by one or more heteroatoms, each optionally substituted with R1 and R2; L is selected from H, chlorine, fluorine, bromine, iodine, OH, O (alkyl), amine, alkyl, fluoroalkyl, amide, N02, SH, S (O) n (alkyl), S03H, SO3alkyl, aldehyde, ketone, acid, ester, urea, Oalkylamide, Oalkylester, Oalkylacid, Nalkylacid, alkylamine, alkylamide, alkylketone, alkylacid, alkylester, alkylurea, Nalkylamide, Nalkylester, NC (=O) alkyl, NC (=O) aryl, NC (=O) cycloalkyl, NC (=O) cycloalkylalkyl, NC (=O) alkylaryl, Ri, R2, nitrile; ---represents an optional additional bond. Also covered are the manufacture of pharmaceuticals from said quinolinones and their use in the treatment of thrombotic disorders in mammals.
Patent NZ-506913-A (NZ)
Title: Hypnotic beta-carboline derivatives as analogues of endogenous acetylated metabolites of melatonin
Inventor: FOURTILLAN JEAN-BERNARD
IPC: A61P25/22
Filed: 1999-03-17
Abstract: A b-carboline derivative has the formula (Ia') or (Ia") wherein: X is -NH- or -CH=CH-; R2 is hydroxyl or alkoxy; R3 is H or alkyl; R8 is optionally substituted alkyl or aryl; R11 is O or S and R14 and R15 are independently hydrogen, alkyl, cycloalkyl, haloalkyl, perhaloalkyl, aryl, aralkyl, alkoxy, cycloalkoxy, mono or polyhaloalkoxy, aryloxy, aralkyloxy, hydroxyalkyl, alkyloxyalkyl, alkylthio, cycloalkylthio, mono or polyhaloalkylthio, arylthio, aralkylthio, formate, alkylcarbonyloxy, cycloalkoxycarbonyl, haloalkoxycarbonyl, aryloxycarbonyl, aralkyloxycarbonyl, dialkylaminoalkyl, dialkylamino, diarylamino, diaralkylamino, optionally substituted carboxamide, fornamide, alkylcarbonylamino, cycloalkylcarbonylamino, haloalkylcarbonylamino, perhaloalkylcarbonylamino, arylcarbonylamino, aralkylcarbonylamino, formyl, alkylcarbonyl, cycloalkylcarbonyl, haloalkylcarbonyl, perhaloalkylcarbonyl, arylcarbonyl, aralkylcarbonyl, carboxyl, alkoxycarbonyl, cycloalkoxycarbonyl, haloalkoxycarbonyl, aryloxycarbonyl, aralkyloxycarbonyl, alkylsulphonyl, cycloalkylsulphonyl, haloalkylsulphonyl, perhaloalkylsulphonyl, arylsulphonyl, aralkylsulphonyl, cyano or nitro radical. The compounds are useful for treating diseases associated with disorders of melatonin activity, depression, psychiatric disorders, sleeping disorders associated with traveling ("jet lag"), neurodegenerative diseases of the central nervous system and cancers.
Patent NZ-507379-A (NZ)
Title: Synergistic herbicidal agents based on phosphorus containing foliar herbicides; imidazolinones and growth promoting herbicides.
Inventor: ANTHONYSAMY DANIEL
IPC: A01N57/20
Filed: 1999-03-30
Abstract: Herbicidal agents containing a combination (A)+(B)+(C) of (A) leaf-effective herbicides from the group of glufosinates and the esters and salts thereof, glufosinate peptides, such as bialaphos, and the salts thereof, glyphosates and the salts thereof, e.g. also sulfosates, (B) imidazolinone herbicides and the salts thereof and (C) one or more active substances from the group of hormone weed-killers and the salts thereof. Said herbicidal agents have synergistic herbicidal effects.
Patent NZ-509506-A (NZ)
Title: Soluble molecules with sequences from CD28, CD86, CD80, CD40 or gp30, from the extracelluar domain of mutant CTL4 and an identification tag
Inventor: PEACH ROBERT J
IPC: C07K14/47
Filed: 1998-01-29
Abstract: An isolated soluble CTLA4 mutant molecule comprises sequences from three molecules. The first amino acid sequence is of a glycoprotein selected from CD28, CD86, CD80, CD40 and gp30. The second amino acid sequence comprises a portion of the extracellular domain of mutant CTLA4. The third amino acid sequence is an identification tag or enhances the solubility of the soluble CTLA4 mutant molecule. The third sequence can correspond to amino acid residues of the hinge, CH2 and CH3 regions of a non-immunogenic immunoglobin molecule or of the molecules p97, env gp120, E7 or ova.
Patent NZ-514174-A (NZ)
Title: Rosinamine derivatives useful as anti-fouling agents
Inventor: KUNISCH FRANZ
IPC: A01N47/44
Filed: 2000-03-10
Abstract: The rosinamine derivatives useful as antifouling agents have the formulae I1 to l3 and I5 to I13 wherein: R1 is NR2R3, N=CR6R7, isonitrile, isocyanate, isothiocyanate or guanidine; R2 is H or alkyl; R3 is C=OR4; R4 is H, OR5 or NHR5; R5 is an optionally substituted alkyl or aryl and n is 0 or 1 excluding tetrahydroabietic isocyanate and dehydroabietic isocyanate.
Patent NZ-514205-A (NZ)
Title: Combination therapy of angiotensin converting enzyme inhibitor and the epoxy-steroidal aldosterone antagonist eplerenone for treatment of cardiovascular disease
Inventor: ALEXANDER JOHN C
IPC: A61P9/00
Filed: 2000-03-03
Abstract: Combinations of an ACE inhibitor and an epoxy-steroidal aldosterone receptor antagonist are described for use in treatment of circulatory disorders. Of particular interest are therapies using epoxy-steroidal-type aldosterone receptor antagonist compounds, such as eplerenone, in combination with an angiotensin converting enzyme inhibitor. This co- therapy would be particularly useful to treat congestive heart failure while avoiding or reducing aldosterone-antagonist- induced side effects such as hyperkalemia.
Patent NZ-514612-A (NZ)
Title: Derivatives of venlafaxine and methods of preparing and using the same
Inventor: JERUSSI THOMAS P
IPC: C07C215/64
Filed: 2000-03-31
Abstract: Methods of preparing, and compositions comprising, derivatives of venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders.
Patent NZ-515468-A (NZ)
Title: Hook fitting for gaffe with molded substance about hook
Inventor: MORRIS PHILIP RICHARD
IPC: A01K97/14
Filed: 2001-11-14
Abstract: A method of forming a hook fitting for the use in producing a gaff, comprising the steps of: (a)  Obtaining a mold and a hook; (b)  Arranging a part of the hook within the mold; (c)  Positioning, by way of injection molding, a suitable settable substance in the mold such that the settable substance is molded to the part of the hook.